- Home
- JEQ vs BOLD Comparison
JEQ vs BOLD Comparison
Compare JEQ & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JEQ
- BOLD
- Stock Information
- Founded
- JEQ 1990
- BOLD 2018
- Country
- JEQ United States
- BOLD United States
- Employees
- JEQ N/A
- BOLD N/A
- Industry
- JEQ Air Freight/Delivery Services
- BOLD
- Sector
- JEQ Consumer Discretionary
- BOLD
- Exchange
- JEQ Nasdaq
- BOLD Nasdaq
- Market Cap
- JEQ 123.9M
- BOLD 24.4M
- IPO Year
- JEQ N/A
- BOLD 2024
- Fundamental
- Price
- JEQ $8.78
- BOLD $1.15
- Analyst Decision
- JEQ
- BOLD Buy
- Analyst Count
- JEQ 0
- BOLD 4
- Target Price
- JEQ N/A
- BOLD $4.00
- AVG Volume (30 Days)
- JEQ 32.0K
- BOLD 77.7K
- Earning Date
- JEQ 01-01-0001
- BOLD 11-06-2025
- Dividend Yield
- JEQ 7.05%
- BOLD N/A
- EPS Growth
- JEQ N/A
- BOLD N/A
- EPS
- JEQ N/A
- BOLD N/A
- Revenue
- JEQ N/A
- BOLD N/A
- Revenue This Year
- JEQ N/A
- BOLD N/A
- Revenue Next Year
- JEQ N/A
- BOLD N/A
- P/E Ratio
- JEQ N/A
- BOLD N/A
- Revenue Growth
- JEQ N/A
- BOLD N/A
- 52 Week Low
- JEQ $4.99
- BOLD $1.00
- 52 Week High
- JEQ $6.39
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- JEQ 77.50
- BOLD 49.88
- Support Level
- JEQ $7.82
- BOLD $1.13
- Resistance Level
- JEQ $8.21
- BOLD $1.16
- Average True Range (ATR)
- JEQ 0.13
- BOLD 0.04
- MACD
- JEQ 0.05
- BOLD 0.00
- Stochastic Oscillator
- JEQ 98.97
- BOLD 55.56
About JEQ abrdn Japan Equity Fund Inc.
Aberdeen Japan Equity Fund Inc is a United States-based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis (including appreciation and dividends), the Tokyo Stock Price Index ("TOPIX"). The fund seeks to achieve its investment objective by investing a majority of its assets, in equity securities of companies listed on the Tokyo Stock Exchange or listed on the over-the-counter market in Japan or listed on other stock exchanges in Japan. The portfolio of investments is spread across Consumer Discretionary, Industrials, Information Technology, Financials, and other sectors.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.